Future Fields and Jenthera Use Fruit Flies for In Vivo CRISPR Therapy
Future Fields and Jenthera Use Fruit Flies for In Vivo CRISPR Therapy
The two companies lay the groundwork for a cost-effective and sustainable method of mass-producing therapeutic recombinant proteins.
State-of-the-art CRISPR for in vivo and cell-based studies in
Scientists Identify Molecular Pathway That Helps Moving Cells
Enhanced Specificity and Efficiency of the CRISPR/Cas9 System with
Chris Fetterly on LinkedIn: Future Fields and Jenthera Use Fruit
State-of-the-art CRISPR for in vivo and cell-based studies in
State-of-the-art CRISPR for in vivo and cell-based studies in
Moeez Ahmed Khan (@KhanMak12) / X
How tech startup Future Fields uses fruit flies to advance the
RNAi in fruit flies (Diptera: Tephritidae): Successes and
Expanding the horizons of genome editing in the fruit fly with
Using TRiP-CRISPR lines DRSC/TRiP Functional Genomics Resources
Multiplex CRISPR/Cas9-mediated knockout of the phytoene desaturase
CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue
Commonly used delivery methods of the CRISPR system in Drosophila
New gene drive technology evokes hopes and fears
